Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin

JM216, an oral platinum drug entering into phase III clinical trial, exhibited comparable cytotoxicity to cisplatin in three human ovarian carcinoma cell lines: the sensitive (CH1), acquired resistant (CH1cisR) and intrinsically resistant (SKOV-3). Platinum accumulation and binding to DNA were simil...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: O’Neill, C F, Koberle, B, Masters, J R W, Kelland, L R
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1999
Teme:
Regular Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362973/
https://ncbi.nlm.nih.gov/pubmed/10604725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6694381
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki